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Abstract
Background: Self-reported substance use is more likely to be influenced by underreporting bias compared to the
biological markers. Underreporting bias or validity of self-reported substance use depends on the study population
and cannot be generalized to the entire population. This study aimed to compare the validity of self-reported
substance use between research setting and primary health care setting from the same source population.
Methods and materials: The population in this study included from Rafsanjan Youth Cohort Study (RYCS) and
from primary care health centers. The sample from RYCS is made up 607 participants, 113 (18.62%) women and 494
(81.38%) men and sample from PHC centers is made up 522 individuals including 252 (48.28%) women and 270
(51.72%) men. We compared two groups in respect of prevalence estimates based on self-reported substance use
and urine test. Then for evaluating validity of self-reported substance use in both group, the results of reference
standard, urine tests, were compared with the results of self-reported drug use using measures of concordance.
Results: The prevalence of substance use based on urine test was significantly higher in both settings compared to
self-reported substance use over the past 72 h. The sensitivity of self-report substance use over the past 72 h in
research setting was 39.4, 20, 10% and zero for opium, methadone, cannabis and amphetamine, respectively and in
primary health care setting was 50, 20.7, 12.5% and zero for opium, methadone, cannabis and amphetamine,
respectively. The level of agreement between self-reported substance use over the past 72 h and urine test
indicated fair and moderate agreement for opium in both research and primary health care settings, respectively
and also slight agreement for methadone and cannabis in both settings were reported. There was no significant
difference between the two groups in terms of self-reported substance use. For all substances, the level of
agreement increased with longer recall periods. The specificity of self-report for all substances in both groups was
more than 99%.
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Conclusion: Individuals in primary health care setting were more likely to self-reported substance use than in
research setting, but setting did not have a statistically significant effect in terms of self-reported substance use.
Programs that rely on self-reported substance use may not estimate the exact prevalence of substance use in both
research and primary health care settings, especially for substances that have a higher social stigma. Therefore, it is
recommended that self-report and biological indicators be used for more accurate evaluation in substance use
studies. It is also suggested that future epidemiological studies be performed to reduce bias of social desirability
and find a method providing the highest level of privacy.
Keywords: Substance use, Self-reported, Underreporting, Validity, Research setting, Primary health care settings
Background
Several epidemiologic studies have been performed to
estimate the substance use in population-based samples
of adults and adolescents worldwide including Iran [1,
2].
Accurate measurement of substance use among youth
and adolescents are important to design and develop
prevention programs. High-quality data can contribute
to the efficient and appropriate use of limited resources
and reduction in some high-risk behaviors. However, es-
timating the prevalence of substance use in a representa-
tive population may yet result in an inaccurate
measurement due to underreporting [3]. Measurement
error is considered as an observed difference between
the real and the obtained values of a measurement [4].
Despite recent advances in biological assays which con-
tributes to the improvement of measuring and evaluat-
ing the prevalence of substance use, researchers rely on
self-reported information in the epidemiological studies
to save time, cost, resources, and the possibility to col-
lect required information on a larger scale [4, 5].
Substance use in societies, depending on cultural and
social circumstances, is often considered as a sensitive,
stigmatized, shameful and even illegal act, so self-
reporting may be subject to secrecy, deception and bias
[2, 5]. Therefore, for these reasons, the validity of the
self-reported data has been questioned [6]. Numerous
studies have shown that self-reported information about
substance use cause underreporting in comparison with
biological tests; that prone these studies susceptible to
measurement errors such as self-reported bias and devi-
ations of the real results [4, 6–11]. However, the amount
of self-reported bias depends on the study population
and cannot be generalized to the entire population [8].
Previous studies have shown that variation in the accur-
acy of self-reported data about substance use depending
on substance type, age, data collection settings, educa-
tion, socioeconomic status and region [12–14].
In Iran, the history of opium use as a recreational and
medicinal substance dates back to more than four cen-
turies [4]. Iran has the highest rate of opioid use in the
world. In recent years, the use of heroin, ecstasy and
crystal methamphetamine has increased. Based on the
results of a national household survey, the prevalence of
substance use in Iran, the most common of which was
opium, estimated 2% [1]. However in Iran, due to some
social and cultural beliefs and legal restrictions, it is not
possible to estimate the absolute prevalence of illegal
drugs [4, 15].
In recent years, one of source for gathering informa-
tion on the prevalence of substance use in Iran were
population-based epidemiological studies such as general
population-based cohort studies. Rafsanjan Youth Co-
hort study (RYCS) as one the hub centers of Persian
Youth Cohort (PYC) [16] was launched in 2016 in Raf-
sanjan city in order to evaluate wide range of psychiatric
disorders and problems, such as illegal drugs and other
high-risk behaviors, accidents, and injuries in a popula-
tion of 15–34 years (born between 1982 and 2001) [17].
Thus, in RYCS, validity of information such as self-
reported substance is questioned. Although, Abnet et al.
reported a high rate of sensitivity of opium use in a
population cohort study among Turkmen in northern of
Iran [18],but it has been shown that the Turkmen popu-
lation uses opium as a traditional medicine with a low
social stigma [18]. Also, Ashrafi et al. showed that the
validity of self-reported drug use was low in Azar popu-
lation based cohort study [4].Thus, this sensitivity is not
constant and may vary for different geographical areas in
Iran as well as for different types of substances.
In addition, one other of source for gathering informa-
tion on the prevalence of substance use and its severity
among youth in Iran is the Integrated Health System
(IHC) of the Ministry of Health. The Integrated Health
System aimed to provide health services in the form of
health system transformation plans and projects in Iran.
All information on households, types of health services
needed in community health centers and bases, and
health homes is entered and recorded in this system. In
other words, IHS has been designed and implemented
with the aim of obtaining and updating information re-
lated to the health status of the Iranian population and
maintaining this information in the population based na-
tional electronic health record (EHR) [19, 20]. The elem-
entary version of the online system was presented to the
Iran Ministry of Health in 2015 and has become to the
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source of collection epidemiological information from
the community, for health policy makers as well as
HCPs providing health care [21]. Thus, in PHC, validity
of information such as self-reported substance is
questioned.
Studies examined the self-report use of various drugs
in comparison to biological tests have widely focused on
specific samples in limited areas such as prisoners, pa-
tients, people in a particular occupation or people with
substance use disorder, while population-based valid-
ation studies are scarce [4, 22]. Since the first step in the
problem-solving process is always to determine the mag-
nitude of the problem in terms of frequency, severity,
and recognition of the current situation, accurate meas-
urement of substance use are important to design and
develop prevention programs. For these reasons, Deter-
mine and compare the validity of the self-reported sub-
stance use in research setting and primary health care
setting, are important to design and develop prevention
programs. However, to the best of our knowledge, little
is known about the difference in the Validity of Self-
Reported Substance Use in Research Setting and Primary
Health Care Setting. For this reason, this study aimed to
(i) examine and quantify whether prevalence of drug use
in people who volunteered for Participation in youth co-
hort study differ from non-participants. (ii) Determining
the concordance between results of self-reported drug
use with the results of urine tests in the early phase of
the Rafsanjan Youth Cohort Study. (iii) Determine and
compare the validity of self-reported substance use be-
tween research setting and primary health care setting
among youth and adolescents in Rafsnjan area in Iran,
which selected from a geographical area with similar so-
cioeconomic and cultural characteristics. The best of our
knowledge, the current paper is the first study in this re-
gard in the youth and adolescent population.
Materials and methods
Study sample
Rafsanjan Youth Cohort study (RYCS) is one of the aca-
demic centers of the PYC study carried out on 3000
youth population (aged 15–34 years/born in 1982–1991)
which started in 2016 in both urban and rural areas of
Rafsanjan city. A comprehensive questionnaire was
asked by trained interviewers in the phase of baseline
data collection and biological specimens (urine, blood,
hair and nails) were collected from December 2016 to
December 2018. Follow-up visits are in progress [17].
The current study was conducted on a subset of those
invited to the RYCS including participants and non-
participants (Fig. 1). The population in this study in-
cluded from RYCS and from primary care health
centers.
Rafsanjan youth cohort study (RYCS)
The sample from RYCS is made up 607 participants, 113
(18.62%) women and 494 (81.38%) men. All participants
were included in the initial phase of the RYCS (baseline
data collection) from March 2018 to December 2018.
Primary health care setting
Sample from PHC centers is made up 522 individuals in-
cluding 252 (48.28%) women and 270 (51.72%) men. It
should be noticed that participants from PHC centers
were among those invited to participate in the RYCS at
the initial phase but they were not willing to take part in
the this cohort but they were recruited by PHC centers’
health officers for annual and periodic health screening
Fig. 1 Flowchart of study sample, Rafsanjan Youth Cohort Study and PHC Centers setting
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tests and examination. We selected a subset of 730 indi-
viduals, including 330 women and 400 men, among
those invited to participate in the RYCS but were not
willing to take part in the study. Then, these people were
asked to go to the primary health care center for a com-
prehensive assessment of their health status and a
checkup by health care providers and physicians present
at the health center (body mass index, lipid and blood
glucose testing, oral and dental hygiene, mental, social
and nutrition health). Participants, who participated
through PHC, have no information about current re-
search. Among these 253 male and 242 female referred
to the health center to assess their health status and
among them, 171 women and 229 men were willing to
give blood and urine samples. Seventeen men and ten
women only agreed to the telephone interview (Fig. 1).
Measures
Self-reported substance use In RYCS, a large number
of questionnaires were completed by well-trained psy-
chologists, which one of is substance use
Questionnaires.
In the RYCS group, participants were asked about any
substance use over the past 12 months and 72 h. Ques-
tions were about opioid use including crude opium,
syrup (extracts from opium residues) and burnt (opium
residues), heroin and crack. Also, history of use of other
substances including methadone, cannabis, amphet-
amine and methamphetamine was also questioned. For
example, the questions regarding opium use (and other
drug) were “Have you used opium over the past 12
months?”, If so, “Have you used opium over the past 72
hours?”
In the primary care health centers group, aforemen-
tioned which were part of the protocol of the Ministry
of Health’s youth and middle ages program were asked
by the health care providers at the health center when
assessing health status. Health care providers were also
public health or midwifery experts trained in the field.
All questionnaires were asked by trained interviewers.
Four psychologists trained by a group of expert in order
to interview with participants in the RYCS, in a one-day
workshop. Also In the primary care health centers
group, similar in the RYCS, Trained interviewers asked
all questionnaires. For this purpose, five Health care pro-
viders trained by a group of expert in order to interview
with participants in the primary care health centers, in a
one-day workshop. All the questionnaires used in this
study were prepared as a software program and the in-
terviews were conducted face-to-face and individual re-
sponses were entered directly into the computer by
interviewers. Experts introduced the study to the partici-
pants. If they were not willing to respond, they were
excluded and the reasons for their refusal to study were
recorded.
Urine drug screen Approximately 5 ml urine sample
was collected from all individuals were willing to give
urine samples at the time of data collection. Urine sam-
ples were tested for morphine, methadone, cannabis,
amphetamine and methamphetamine by using Urine
Rapid Drug Screen (URDS).Thin Layer Chromatography
(TLC) performed as the reference Standard to determine
substance use. The TLC test was used for participants
with a positive URDS test. In respect of initial screening,
the URDS test was used to detect the existence of drug
metabolites including morphine (cutoff point: 300 ng/
ml), cannabis (cutoff point: 50 ng/ml), amphetamine and
methamphetamine (cutoff point: 500 ng/ml), and metha-
done metabolites (cutoff point: 300 ng/ml). Metabolites
of morphine and methadone can be detected in the
urine by 72 h after being used and metabolites of am-
phetamine and methamphetamine can be detectable by
96 h after use [23]. Consequently, the TLC test was used
for participants with a positive URDS test. The sensitiv-
ity of the URDS is above 98%. Sensitivities for the URDS
compared to TLC ranged from 96% for cocaine to > 99%
for Opioids [24]. Urine samples were analyzed by labora-
tory in Rafsanjan University of Medical Sciences.
Statistical analysis
To describe the data, mean and standard deviation for
quantitative variables and frequency and percentage for
qualitative variables were reported.
In this study, the results of standard tests (urine test)
were compared with the results of self-report data about
substance use by McNamara’s test. Conditional kappa,
sensitivity and specificity were used for calculating
agreement and concordance between laboratory tests
and self-reported results in the past 72 h. Traditional
Cohen’s kappa evaluates the agreement between the two
criteria after correcting the effect of chance and acci-
dent, and considers the probability of equal error for
both parties. In contrast, conditional kappa maintains
just a variable such as urine test as criterion and after
correcting the effect of chance, assesses the agreement
of the other measurement according to the urine test
[25]. The kappa values ≤0.20% considered as Poor, 0.21–
0.40 Fair, 0.41–0.60 moderate, 0.61–0.80 Substantial,
0.81–1.00 Almost Perfect [26]. Moreover, Conditional
kappa and sensitivity were also used to describe con-
cordance between self-reported substance use in the past
12 months and laboratory test results. Specificity was not
calculated for self-reported substance use over the past
year, as some people may have correctly self reported
substance use over the past year, but a urine test could
not determine substance use over the past year, so it
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mistakenly could raise the number of false negatives. Fi-
nally, Chi square test and multivariable logistic regres-
sion model was used to assess the validity of self-
reported substance use in during the past 72 h among
urinalysis-confirmed users in group of Primary health
care setting compared to group of RYCS. For sufficiently
power analysis of low prevalence substances, in multi-
variable logistic regression model we collapsed all drugs.
Variable gender include in the multivariable logistic re-
gression model. All statistical analyses were performed
through STATA version 14 except conditional kappa,
which was calculated in Microsoft Excel.
Ethical considerations
The ethics committee of Rafsanjan and Iran University
of Medical Sciences (#IR.RUMS.REC.1397.243 and
IR.RUMS.REC.1398.042) approved this study. Written
informed consent was obtained from the participants.
The data of participants kept confidential, and urine
samples were kept anonymous for researchers so that
the results were not related to the identities of the par-
ticipants in the dataset. To reach this goal, the urine
samples were transported into the container with the
unique number to identify whether each sample
belonged to a male or female as well as the kind of sub-
stance being used.
Results
This study included 1129 participants, 494 men (81.38%)
and 113 women (18.62%) in the RYCS (Research Setting)
group with the mean age of 28.04 ± 6.18 years and 270
men (51.72%) and 252 women (48.28%) in PHC setting
group with the mean age of 29.11 ± 9.43 years. The de-
tails of demographic characteristics including age and
gender was presented (Table 1).
Prevalence of self-reported substance use in the RYCS
(research setting) versus PHC (primary health care)
setting
Table 2 presents the prevalence of each substance use
estimated through urine test and self-reporting. Overall,
regarding opium use, the prevalence of self-reported
substance use in the past 72 h was statistically lower in
men who were in the RYCS group (2.43%) than in the
PHC group (6.99%) but not for other substance use, also
the prevalence estimates based on urinalyses for all
substance use were significantly higher in men of PHC
group. In other words, men in PHC group, compared to
men in RYCS group, were more often the recent sub-
stance user. Although, the prevalence of all substance
use over the past 12 month was higher in men who were
in the PHC group compared to the RYCS group, but
there was no statistically significant difference between
the two groups in this regard.
In addition, the prevalence of opium use over the past
72 h was no significantly different between the two
groups of women. The prevalence of opium use over the
past 12 months was significantly different between the
two groups of women. In other words, women in PHC
group had lower self-report of opium use over the past
12 months compared to the RYCS group.
Concordance between urine test and self-report
substance use
As shown in table 2, based on McNamara’s test results,
Regarding all drugs, the prevalence estimates based on
urine test were significantly higher in both groups com-
pared to self-reporting over the past 72 h (p < 0.001).
Table 3 shows concordance value between self-report
substance use with different recall periods and having a
positive urine test. Sensitivity of self-report (i.e., number
of self-reported substance use divided by detected sub-
stance users through a urine test) in men of RYCS group
were 37.5, 21.1 and 10% for morphine, methadone and
cannabis respectively and in the PHC group were 53.3,
24 and 12.5% over the past 72 h but with increasing the
length of the recall period, this index increased in both
groups.
Although, overall, the validity of self-reported opium
and methadone use in men who were in the PHC group
was lower than men in the RYCS group, but there was
no statistically significant difference between the two
groups in this regard.
For example, the use of opium and its derivatives in
the RYCS group in comparison with the results of urine
test, only about 37.5% of men with a positive test results
had a true self-report substance use over the past 72 h.
In the PHC group, about 53.3% of men over the 72 h
had a true self-report substance use; However, the re-
sults of chi-square test showed that there was no statisti-
cally significant difference between the two groups in
this regard (p = 0.211).
Table 1 Demographic characteristics of the participants (N = 1129)
Variable M (SD) or n (%) p
RYCS/ research setting primary health care setting
Sex Male 494 (81.38) 270 (51.72) –
Female 113 (18.62%) 252(48.28)
Age 28.04 ± 6.18 29.11 ± 9.43 0.023
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In addition, in the last 12 months, these ratios have
reached about 56.3 and 70% for RYCS and PHC groups,
respectively.
For substance other than opium, the sensitivity of self-
reporting was lower but increased slightly with longer
recall periods in both groups. The sensitivity of self-
reporting about opium use over the past 72 h for women
in RYCS group and PHC group were 100 and 25%, re-
spectively. In general, underreporting for opium use was
higher in women in the PHC group than in the RYCS
group. However, it should be noted that while interpret-
ing these results, among women who had a positive
urine test (1 woman in RCYS group and 4 woman in
PHC group), only a small minority of women (only 1in
each group) had a true self-report opium use during the
previous 72 h. This may explain non-concordance be-
tween two settings. However, the results showed that
there was no statistically significant difference between
the two groups in this regard (p = 0.171).
The specificity of self-reporting about substance use
(i.e., number of negative self-reported divided by those
with negative urine tests) for all drugs in both gender
and both groups were > 99%. Conditional kappa or the
level of agreement between self-report substance use
over the past 72 h and urine tests revealed fair agree-
ment for opium and methadone and slight for cannabis
in men who were in the RYCS group and indicated
moderate, fair and slight agreement for opium, metha-
done and cannabis in men in the PHC group,
respectively.
For all substances, conditional kappa increased with
longer recall periods. Also, in women, level of agreement
between Self-reported substance use over the past 72 h
and urine test indicated almost perfect agreement and
fair for opium in RYCS and PHC groups, respectively.
Notably, in both groups who had given a urine sample,
there were no reports of amphetamine and metham-
phetamine in both genders as well as for methadone and
cannabis in women. While, prevalence estimated using
urine test for methadone use in women were 0.88%
(only one woman) and 2.34% (four women) in RYCS
and PHC groups, respectively and for amphetamine and
methamphetamine use in men were 0.20% (only one
man) and 0.87% (two men) in RYCS and PHC groups,
respectively. (Also, Supplementary Table 1, Additional
file, shows concordance value between self-report sub-
stance use in different recall periods and having a posi-
tive urine test after combine both groups.)
Finally, Table 4 presents results of the multivariable logistic
regression model for self-reporting substance use in group of
PHC compared to group of RYCS. Although, relative to
group of RYCS, group of PHC had greater odds of self-
reported substance use during the past 72 h, but was no sig-
nificant difference between the two groups in this regard.
Discussion
In the present study, the effect of data collection set-
tings, research setting versus primary health care setting,
on the estimated prevalence of substance use and
reporting bias in the two groups of youth and adoles-
cents were investigated. From this perspective, the best
of our knowledge, the current paper is the first study in
the youth and adolescent population. It should be noted
that sample in this study was selected from a geograph-
ical area with similar socioeconomic and cultural charac-
teristics. Self-reported opium and methadone use over
the past 72 h in men who were in the PHC group was
higher than men in RYCS (research setting) group. Also
the prevalence estimates based on urine test for all sub-
stances were higher in men who were in PHC group. As
well as, there was a significant difference between the
two groups of women in favor of opium use over the
past 12 months. In other words, women who were in the
RYCS group had lower self-report of opium use over the
past 12 months.
The level of agreement between self-reported sub-
stance use over the past 72 h and urine test indicated fair
and moderate agreement for opium in research and pri-
mary health care settings in men, respectively. In
addition, the level of agreement between self-reported
substance use over the past 72 h and urine test were fair
for methadone and slight for cannabis in both settings.
Conditional kappa indicated that in research setting ver-
sus primary health care setting, men were less willing to
self-reported opium use.
Clark and colleagues demonstrated that individuals are
usually more honest about substance use when the tar-
get is treatment. However, individuals tend to deny sub-
stance use when the target is not treatment [27].
In women, the results were the opposite, in which level
of agreement between self-reported substance use over
the past 72 h and urine test indicated almost perfect and
fair agreement for opium in research setting and primary
health care setting, respectively. Also, the level of agree-
ment for methadone in both research setting and pri-
mary health care setting were slight. Nevertheless,
overall, based on result of multivariable logistic
Table 4 Multivariable logistic regression model of self-reporting
substance use in during the past 72 h among urinalysis-
confirmed users
AORa 95% CI p
Self-reported drug use during the past 72 h
PHC group (Ref = RYCS group) 1.25 (0.56–2.77) 0.590
aadjusted for gender (male/ female)
dds ratio was not calculated to compare of self-reported substance use over
the past year, as some people may have correctly self-report of substance use
over the past year, but a urine test could not determine substance use over
the past year
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regression model about self-reporting of substance use
in over the past 72 h among urinalysis-confirmed users,
although, relative to group of RYCS, group of primary
health care (PHC) had greater odds of self-reported sub-
stance use, but was no significant difference between the
two groups in this regard.
Although the answer to any sensitive question is ex-
pected to be influenced by the data collection settings,
but it is more influenced by factors such as desirability
and social stigma, public opinion about substance use,
or potential legal sanctions, and may lead to reluctance
for participants to report use [28]. Behaviors that are il-
legal, stigmatized, or have moral consequences may be
less likely to be reported.
One way to evaluate whether self-reports substance
use are affected by social desirability or legal sanction is
to compare reports obtained under different methods
that have various levels of privacy and anonymity. In
various methodological studies, the higher self-reported
substance use was observed in a study that provided the
highest level of privacy. In general, prevalence estimates
increase as privacy and confidentiality increase [29]. In
this study, similar method and similar levels of privacy
and anonymity were used to evaluate substance use in
the two different settings (research and non-research)
that indicated there was no significant difference be-
tween the two settings in respect the validity of self re-
ported substance use, especially regarding certain
substances, which are more stigmatized.
The results of this study led to concerning conclu-
sions. We observed low sensitivity and high specificity of
self-reported substance use compared to urine tests as
the reference standard in the two settings, especially re-
garding certain substances, which are more stigmatized.
Our results confirmed the general belief that people who
are not drug users often tell the truth showing high
specificity while some substance users who deny the real
experience which lead to prove low sensitivity of self-
reported substance use. These results were in line with
by Ashrafi’s study. They showed that validity of self-
reported substance use was low in Azar cohort as a
population based study [4].
However, the validity of self-reported substance use
over the past 72 h was lower in our study compared to
other studies, which reported a good validity. Study by
Abnet et al. reported a high sensitivity of opium use in
Turkmen population in northern Iran [18]. Also, Zaldí-
var et al. showed a high validity of the self-report canna-
bis use and moderate validity for cocaine use in
comparison with the urine test in college students [5].
Sensitivity and specificity are not constant and may vary
for different setting, genders, age groups, samples and
geographical areas as well as for different types of sub-
stances. Most possible explanation for this issue could
be the beliefs and social and cultural differences for vari-
ous regions and individuals [4, 27]. The amount and pat-
tern of substance use denial vary for different
substances, but generally, more stigmatized substances
are denied more than less stigmatized substances.
This can be explained by the fact that respondents
may be inconvenient to discuss about their substance
use due to some reasons including public opinion,
disgrace, embarrassment and fear of legal conse-
quences [2, 22, 30]. Bradburn and Sudman have also
reported the sensitive nature of substance use in a re-
search conducted in the US, which indicated the in-
convenience feeling to discuss about these topics, by
respondents [31]. .Since consumed opium in this
population was with less social stigma than other sub-
stances the validity of reporting of this substance was
higher in compare to other substances which this
finding are supported by some research results that
indicating substance use underreporting increases
with the level of its stigma [2, 22].
Finally, further analysis showed that validity of self-
report substance use over the past year was higher com-
pared to over the past 72 h in the two groups. However,
it should be noted, that the urine test only detects sub-
stance use over the past 72 h and is not able to detect
substance over longer periods. Therefore, it can be con-
cluded that in people who have been using substance re-
cently (urinalysis-confirmed users), questions regarding
past substance use are likely to generate less underre-
porting in comparison with those concerning recent
substance use. In a study, Harrison found that underre-
porting had little or no effect on self-reported lifetime
use, more on self-reported use past year, and most on
self-reported use last month. Consistent with the results
of our study, Harrison Found that Valid self-reporting of
substance use is a function of ‘1) the recency of the
event, 2) the social desirability of the substance [32].
Thus, we suggest that the estimates of substance use in
past year in self-report studies are likely more valid then
past 72 h.
Some studies found that questions regarding past sub-
stance use are likely to generate less underreporting
when compared with those concerning recent substance
use [22, 33]. The contrast between recent and previous
analysis indicated a general unwillingness to the recent
self-report of substance use. Besides, these results sup-
port the concept that self-report substance use over the
past year is more reliable than the recent use in the two
settings (research and non-research).
Compared to biological markers, self-reported data is
usually cheaper and more practical, allowing researchers
to obtain and collect more information on long-term
substance use, methods of use, and user behaviors. Also,
relying on self-reported data is often the only
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appropriate approach to assess substance use, but re-
sponses may be influenced by factors such as report bias,
social desirability, stigma and participant’s ability to re-
call information. Also, social disgrace associated with
substance use or potential legal sanction may lead par-
ticipants to be reluctant to report the use of these illicit
substances, or individuals may even exaggerate experi-
ence of substance use because of gaining certain privi-
leges in some conditions [4, 34]. Therefore, for such
population, according to our results, in two setting, re-
search and primary health care, underreporting cannot
be overlooked and studies on sensitive issues such as
substance use should be taken into careful consideration
in respect of false negative, thus this bias needs to be es-
timated and corrected. Otherwise it could lead to finding
a spurious association.
Limitations
The main limitations of the present study were listed as
following:
 In order to influence the data collection
environment on the validity of self-report substance
use, individuals were not randomly assigned to the
groups. Therefore, other factors may also play a role
in estimating substance use in both environments.
For example, participants in the PHC group were
those who had declined to participate the RYCS,
thus some difference may be due to personality dif-
ferences between the two groups, although they
were selected from a geographical area with similar
socioeconomic and cultural characteristics.
 Appropriate markers are available to identify drug
metabolites for longer periods of time. However,
urine test is considered as a simple, fast, and
inexpensive method for assessing the validity of self-
reported substance use in the epidemiological stud-
ies. There were no protocols for the use of other
biological samples such as hair at the time of this
study.
 People who have been passively exposed to drugs
were not investigated.
Conclusion
Individuals in primary health care setting were more
likely to self-reported substance use than in research set-
ting, but setting did not have a statistically significant ef-
fect in terms of self-reported substance use. Programs
that rely on self-reported substance use may not esti-
mate the exact prevalence of substance use in both re-
search and primary health care settings, especially
substances that have a higher social stigma. Therefore, it
is recommended that self-report and biological indica-
tors be used for more accurate evaluation in substance
use studies. It is also suggested that future epidemio-
logical studies be performed to reduce bias of social de-
sirability and find a method providing the highest level
of privacy.
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